|View printer-friendly version|
|August 23, 2006 1:57 p.m.|
|Teva Announces Further Steps in Global Rationalization Strategy|
Will Close Manufacturing Facility in Cidra in Fourth Quarter of 2006
Jerusalem, Israel, August 23, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that as part of the Company's global rationalization strategy, it will cease production at its manufacturing facility in Cidra, Puerto Rico, during the fourth Quarter of 2006. This is designed to further improve efficiencies, supply chain management and competitive positioning following the acquisition of Ivax in January 2006.